Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Introduction | |
The Industry Structure of Pharmaceutical Innovation | |
The pharmaceutical sector in health care | |
The economics of research and development in the pharmaceutical industry | |
Structuring Incentives for Research and Development | |
Drugs for neglected diseases: new incentives for innovation | |
When patents fail: finding new drugs for the developing world | |
Implementing a public subsidy for vaccines | |
Ensuring the future supply of vaccines: is a National Vaccine Authority the answer? | |
Competition and Marketing | |
Competition between generic and branded drugs | |
The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? | |
Public Evaluation of the Benefits and Costs of Innovation | |
Measures of costs and benefits for drugs in cost effectiveness analysis | |
Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience | |
Pharmaceutical spending and health outcomes | |
Pharmaceutical innovation and health outcomes: empirical evidence from | |
Conclusions and policy implications | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.